0,1,2
us-gaap:accountspayablecurrent,3102000000,FI2017Q4
us-gaap:accountspayablecurrent,3162000000,FI2018Q1
us-gaap:accountsreceivablenetcurrent,6873000000,FI2017Q4
us-gaap:accountsreceivablenetcurrent,7245000000,FI2018Q1
us-gaap:accountsreceivablenetcurrent,7209000000,FI2018Q1_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:accountsreceivablenetcurrent,5000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member
us-gaap:accountsreceivablenetcurrent,5000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_NewAccountingPronouncementMember
us-gaap:accruedincometaxescurrent,708000000,FI2017Q4
us-gaap:accruedincometaxescurrent,717000000,FI2018Q1
us-gaap:accruedincometaxescurrent,713000000,FI2018Q1_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:accumulateddepreciationdepletionandamortizationpropertyplantandequipment,16602000000,FI2017Q4
us-gaap:accumulateddepreciationdepletionandamortizationpropertyplantandequipment,16483000000,FI2018Q1
us-gaap:accumulatedothercomprehensiveincomelossnetoftax,266000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_mrk_AccountingStandardUpdate201802Member
us-gaap:accumulatedothercomprehensiveincomelossnetoftax,8000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201601Member
us-gaap:accumulatedothercomprehensiveincomelossnetoftax,274000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_NewAccountingPronouncementMember
us-gaap:additionalpaidincapitalcommonstock,39902000000,FI2017Q4
us-gaap:additionalpaidincapitalcommonstock,39874000000,FI2018Q1
us-gaap:allocatedsharebasedcompensationexpensenetoftax,52000000,FD2017Q1QTD
us-gaap:allocatedsharebasedcompensationexpensenetoftax,65000000,FD2018Q1YTD
us-gaap:allowancefordoubtfulaccountsreceivablecurrent,210000000,FI2017Q4
us-gaap:allowancefordoubtfulaccountsreceivablecurrent,205000000,FI2018Q1
us-gaap:amortizationofintangibleassets,9000000,FD2018Q1QTD_us-gaap_CounterpartyNameAxis_mrk_AstraZenecaMember_us-gaap_ProductOrServiceAxis_mrk_LynparzaMember
us-gaap:antidilutivesecuritiesexcludedfromcomputationofearningspershareamount,2000000,FD2017Q1QTD
us-gaap:antidilutivesecuritiesexcludedfromcomputationofearningspershareamount,14000000,FD2018Q1YTD
us-gaap:assets,87872000000,FI2017Q4
us-gaap:assets,86041000000,FI2018Q1
us-gaap:assetscurrent,24766000000,FI2017Q4
us-gaap:assetscurrent,24085000000,FI2018Q1
us-gaap:assetsfairvaluedisclosurerecurring,343000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:assetsfairvaluedisclosurerecurring,14970000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:assetsfairvaluedisclosurerecurring,15313000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:assetsfairvaluedisclosurerecurring,396000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:assetsfairvaluedisclosurerecurring,14251000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:assetsfairvaluedisclosurerecurring,14647000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax,11000000,FI2017Q4
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax,1000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax,9000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax,1000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax,4000000,FI2018Q1
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax,1000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax,3000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,79000000,FI2017Q4
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,7000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,40000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,6000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,9000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,17000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,172000000,FI2018Q1
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,17000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,121000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,10000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,1000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax,23000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,14976000000,FI2017Q4
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,1548000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,9837000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,739000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,634000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,2059000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,159000000,FI2017Q4_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,14374000000,FI2018Q1
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,1585000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,9978000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,769000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,79000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,1833000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsaledebtsecuritiesamortizedcostbasis,130000000,FI2018Q1_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsaleequitysecuritiesaccumulatedgrossunrealizedgainbeforetax,16000000,FI2017Q4
us-gaap:availableforsaleequitysecuritiesaccumulatedgrossunrealizedlossbeforetax,6000000,FI2017Q4
us-gaap:availableforsaleequitysecuritiesamortizedcostbasis,265000000,FI2017Q4
us-gaap:availableforsalesecurities,15183000000,FI2017Q4
us-gaap:availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax,27000000,FI2017Q4
us-gaap:availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax,85000000,FI2017Q4
us-gaap:availableforsalesecuritiesamortizedcost,15241000000,FI2017Q4
us-gaap:availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue,10600000000,FI2018Q1
us-gaap:availableforsalesecuritiesdebtsecurities,14908000000,FI2017Q4
us-gaap:availableforsalesecuritiesdebtsecurities,68000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,1476000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,9678000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,732000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,547000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,1767000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,159000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsalesecuritiesdebtsecurities,1476000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,9678000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,732000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,547000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,1835000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,159000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsalesecuritiesdebtsecurities,1542000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,9806000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,733000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,626000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,2042000000,FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,159000000,FI2017Q4_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsalesecuritiesdebtsecurities,14206000000,FI2018Q1
us-gaap:availableforsalesecuritiesdebtsecurities,1517000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,9741000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,759000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,1585000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,130000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsalesecuritiesdebtsecurities,1517000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,9741000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,759000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,1585000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,130000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsalesecuritiesdebtsecurities,1569000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,9860000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,759000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,78000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,1810000000,FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:availableforsalesecuritiesdebtsecurities,130000000,FI2018Q1_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember
us-gaap:availableforsalesecuritiesdebtsecuritiescurrent,2900000000,FI2018Q1
us-gaap:availableforsalesecuritiesequitysecurities,275000000,FI2017Q4
us-gaap:businessacquisitionpercentageofvotinginterestsacquired,0.935,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:businessacquisitionpercentageofvotinginterestsacquired,0.045,FI2017Q4_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:businessacquisitionshareprice,1.75,I2018Q1Feb28
us-gaap:businesscombinationacquisitionoflessthan100percentnoncontrollinginterestfairvalue,25000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsideratio,34000000,FD2017Q1QTD
us-gaap:businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsideratio,36000000,FD2018Q1YTD
us-gaap:businesscombinationcontingentconsiderationliability,891000000,FI2016Q4
us-gaap:businesscombinationcontingentconsiderationliability,925000000,FI2017Q1
us-gaap:businesscombinationcontingentconsiderationliability,935000000,FI2017Q4
us-gaap:businesscombinationcontingentconsiderationliability,935000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:businesscombinationcontingentconsiderationliability,935000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:businesscombinationcontingentconsiderationliability,919000000,FI2018Q1
us-gaap:businesscombinationcontingentconsiderationliability,919000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:businesscombinationcontingentconsiderationliability,919000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:businesscombinationcontingentconsiderationliabilitycurrent,337000000,FI2018Q1
us-gaap:businesscombinationindemnificationassetsamountasofacquisitiondate,37000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcontingentliabil,37000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentassetsoth,32000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumeddeferredtaxliabi,102000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibles,297000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:cashandcashequivalentsatcarryingvalue,6092000000,FI2017Q4
us-gaap:cashandcashequivalentsatcarryingvalue,4483000000,FI2018Q1
us-gaap:cashandcashequivalentsatcarryingvalue,4500000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member
us-gaap:cashcashequivalentsrestrictedcashandrestrictedcashequivalents,6515000000,FI2016Q4
us-gaap:cashcashequivalentsrestrictedcashandrestrictedcashequivalents,11708000000,FI2017Q1
us-gaap:cashcashequivalentsrestrictedcashandrestrictedcashequivalents,6096000000,FI2017Q4
us-gaap:cashcashequivalentsrestrictedcashandrestrictedcashequivalents,4486000000,FI2018Q1
us-gaap:cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincluding,5193000000,FD2017Q1QTD
us-gaap:cashequivalentsatcarryingvalue,3500000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member
us-gaap:changeinunrealizedgainlossonhedgediteminfairvaluehedge1,16000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember
us-gaap:changeinunrealizedgainlossonhedgediteminfairvaluehedge1,62000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember
us-gaap:commonstockdividendspersharedeclared,0.47,FD2017Q1QTD
us-gaap:commonstockdividendspersharedeclared,0.48,FD2018Q1YTD
us-gaap:commonstockparorstatedvaluepershare,0.50,FI2017Q4
us-gaap:commonstockparorstatedvaluepershare,0.50,FI2018Q1
us-gaap:commonstocksharesauthorized,6500000000,FI2017Q4
us-gaap:commonstocksharesauthorized,6500000000,FI2018Q1
us-gaap:commonstocksharesissued,3577000000,FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:commonstocksharesissued,828000000,FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:commonstocksharesissued,3577000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:commonstocksharesissued,837000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:commonstocksharesissued,3577103522,FI2017Q4
us-gaap:commonstocksharesissued,3577000000,FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:commonstocksharesissued,880000000,FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:commonstocksharesissued,3577103522,FI2018Q1
us-gaap:commonstocksharesissued,3577000000,FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:commonstocksharesissued,885000000,FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:commonstockvalue,1788000000,FI2017Q4
us-gaap:commonstockvalue,1788000000,FI2018Q1
us-gaap:comprehensiveincomenetoftax,1697000000,FD2017Q1QTD
us-gaap:comprehensiveincomenetoftax,860000000,FD2018Q1YTD
us-gaap:costofgoodssold,3049000000,FD2017Q1QTD
us-gaap:costofgoodssold,3184000000,FD2018Q1YTD
us-gaap:costofgoodssold,3173000000,FD2018Q1YTD_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:cumulativeeffectofnewaccountingprincipleinperiodofadoption,5000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member
us-gaap:cumulativeeffectofnewaccountingprincipleinperiodofadoption,8000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201601Member
us-gaap:cumulativeeffectofnewaccountingprincipleinperiodofadoption,54000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201616Member
us-gaap:debtandcapitalleaseobligations,24400000000,FI2017Q4
us-gaap:debtandcapitalleaseobligations,23600000000,FI2018Q1
us-gaap:debtcurrent,3057000000,FI2017Q4
us-gaap:debtcurrent,2055000000,FI2018Q1
us-gaap:debtcurrent,14000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_mrk_AccountingStandardUpdate201712Member
us-gaap:debtcurrent,14000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_NewAccountingPronouncementMember
us-gaap:debtinstrumentfaceamount,1000000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A1.30NotesDue2018Member
us-gaap:debtinstrumentfaceamount,1250000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A1.85NotesDue2020Member
us-gaap:debtinstrumentfaceamount,1250000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A2.35NotesDue2022Member
us-gaap:debtinstrumentfaceamount,1000000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A2.40NotesDue2022Member
us-gaap:debtinstrumentfaceamount,1150000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A3.875NotesDue2021Member
us-gaap:debtinstrumentfaceamount,1250000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A5.00NotesDue2019Member
us-gaap:debtinstrumentfairvalue,25600000000,FI2017Q4
us-gaap:debtinstrumentfairvalue,24300000000,FI2018Q1
us-gaap:debtinstrumentinterestratestatedpercentage,0.0130,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A1.30NotesDue2018Member
us-gaap:debtinstrumentinterestratestatedpercentage,0.0185,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A1.85NotesDue2020Member
us-gaap:debtinstrumentinterestratestatedpercentage,0.02350,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A2.35NotesDue2022Member
us-gaap:debtinstrumentinterestratestatedpercentage,0.0240,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A2.40NotesDue2022Member
us-gaap:debtinstrumentinterestratestatedpercentage,0.03875,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A3.875NotesDue2021Member
us-gaap:debtinstrumentinterestratestatedpercentage,0.0500,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A5.00NotesDue2019Member
us-gaap:deferredincometaxliabilitiesnet,2219000000,FI2017Q4
us-gaap:deferredincometaxliabilitiesnet,2206000000,FI2018Q1
us-gaap:deferredincometaxesandotherassetscurrent,4299000000,FI2017Q4
us-gaap:deferredincometaxesandotherassetscurrent,4112000000,FI2018Q1
us-gaap:deferredincometaxesandotherassetsnoncurrent,6075000000,FI2017Q4
us-gaap:deferredincometaxesandotherassetsnoncurrent,6558000000,FI2018Q1
us-gaap:deferredtaxliabilitiesundistributedforeignearnings,2000000000,FI2017Q4_us-gaap_TaxPeriodAxis_mrk_A2017TaxCutsandJobsActTCJAMember
us-gaap:definedbenefitplancostofprovidingspecialorcontractualterminationbenefitrecognizedduringperio,5000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplancostofprovidingspecialorcontractualterminationbenefitrecognizedduringperio,1000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplancostofprovidingspecialorcontractualterminationbenefitrecognizedduringperio,1000000,FD2017Q1QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplancostofprovidingspecialorcontractualterminationbenefitrecognizedduringperio,11000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplancostofprovidingspecialorcontractualterminationbenefitrecognizedduringperio,1000000,FD2018Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplanexpectedreturnonplanassets,218000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanexpectedreturnonplanassets,94000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanexpectedreturnonplanassets,19000000,FD2017Q1QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplanexpectedreturnonplanassets,214000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanexpectedreturnonplanassets,113000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanexpectedreturnonplanassets,21000000,FD2018Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplaninterestcost,113000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplaninterestcost,41000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplaninterestcost,20000000,FD2017Q1QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplaninterestcost,108000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplaninterestcost,46000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplaninterestcost,18000000,FD2018Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplannetperiodicbenefitcost,11000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplannetperiodicbenefitcost,30000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplannetperiodicbenefitcost,30000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplannetperiodicbenefitcost,18000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanrecognizednetgainlossduetocurtailments,3000000,FD2017Q1QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplanrecognizednetgainlossduetocurtailments,2000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanrecognizednetgainlossduetocurtailments,4000000,FD2018Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplanservicecost,77000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanservicecost,61000000,FD2017Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanservicecost,14000000,FD2017Q1QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:definedbenefitplanservicecost,83000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanservicecost,67000000,FD2018Q1QTD_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember
us-gaap:definedbenefitplanservicecost,14000000,FD2018Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
us-gaap:depreciationdepletionandamortization,1193000000,FD2017Q1QTD
us-gaap:depreciationdepletionandamortization,370000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:depreciationdepletionandamortization,350000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:depreciationdepletionandamortization,1137000000,FD2018Q1YTD
us-gaap:derivativeassetfairvalueoffsetagainstcollateralnetofnotsubjecttomasternettingarrangementpoli,33000000,FI2017Q4
us-gaap:derivativeassetfairvalueoffsetagainstcollateralnetofnotsubjecttomasternettingarrangementpoli,6000000,FI2018Q1
us-gaap:derivativeassetnotoffsetpolicyelectiondeduction,94000000,FI2017Q4
us-gaap:derivativeassetnotoffsetpolicyelectiondeduction,103000000,FI2018Q1
us-gaap:derivativeassets,130000000,FI2017Q4
us-gaap:derivativeassets,38000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeassets,2000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeassets,51000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeassets,39000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativeassets,48000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,48000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,80000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,80000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,2000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,2000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,130000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,130000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,91000000,FI2017Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeassets,39000000,FI2017Q4_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativeassets,109000000,FI2018Q1
us-gaap:derivativeassets,30000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeassets,21000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeassets,58000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativeassets,63000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,63000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,46000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,46000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,109000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,109000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeassets,51000000,FI2018Q1_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeassets,58000000,FI2018Q1_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativecollateralobligationtoreturncash,3000000,FI2017Q4
us-gaap:derivativeinstrumentsnotdesignatedashedginginstrumentsgainlossnet,47000000,FD2017Q1YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember
us-gaap:derivativeliabilities,217000000,FI2017Q4
us-gaap:derivativeliabilities,71000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,90000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativeliabilities,3000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,1000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,52000000,FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,162000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,162000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,55000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,55000000,FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,217000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,217000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,127000000,FI2017Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,90000000,FI2017Q4_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativeliabilities,324000000,FI2018Q1
us-gaap:derivativeliabilities,119000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,89000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativeliabilities,1000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,1000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,114000000,FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,208000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,208000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,1000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,1000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,115000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,115000000,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateContractMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,324000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,324000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:derivativeliabilities,235000000,FI2018Q1_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember
us-gaap:derivativeliabilities,89000000,FI2018Q1_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember
us-gaap:derivativeliabilityfairvalueoffsetagainstcollateralnetofnotsubjecttomasternettingarrangement,123000000,FI2017Q4
us-gaap:derivativeliabilityfairvalueoffsetagainstcollateralnetofnotsubjecttomasternettingarrangement,221000000,FI2018Q1
us-gaap:derivativeliabilitynotoffsetpolicyelectiondeduction,94000000,FI2017Q4
us-gaap:derivativeliabilitynotoffsetpolicyelectiondeduction,103000000,FI2018Q1
us-gaap:dividendscommonstockcash,1297000000,FD2017Q1QTD
us-gaap:dividendscommonstockcash,1297000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:dividendscommonstockcash,1301000000,FD2018Q1YTD
us-gaap:dividendscommonstockcash,1301000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:dividendspayablecurrent,1320000000,FI2017Q4
us-gaap:dividendspayablecurrent,1317000000,FI2018Q1
us-gaap:earningspersharebasic,0.56,FD2017Q1QTD
us-gaap:earningspersharebasic,0.27,FD2018Q1YTD
us-gaap:earningspersharediluted,0.56,FD2017Q1QTD
us-gaap:earningspersharediluted,0.27,FD2018Q1YTD
us-gaap:effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents,253000000,FD2017Q1QTD
us-gaap:effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents,154000000,FD2018Q1YTD
us-gaap:effectiveincometaxratecontinuingoperations,0.223,FD2017Q1QTD
us-gaap:effectiveincometaxratecontinuingoperations,0.449,FD2018Q1YTD
us-gaap:employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized,798000000,FI2018Q1
us-gaap:employeeservicesharebasedcompensationtaxbenefitfromcompensationexpense,22000000,FD2017Q1QTD
us-gaap:employeeservicesharebasedcompensationtaxbenefitfromcompensationexpense,15000000,FD2018Q1YTD
us-gaap:escrowdeposit,176000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:fairvalueinputsdiscountrate,0.155,D2017Q1Mar_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitypurchases,8000000,FD2018Q1YTD
us-gaap:fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements,60000000,FD2018Q1YTD
us-gaap:foreigncurrencytransactiongainlossbeforetax,8000000,FD2017Q1QTD
us-gaap:gainlossrelatedtolitigationsettlement,115000000,D2018Q1Jan
us-gaap:goodwill,156000000,FI2017Q1_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:goodwill,18284000000,FI2017Q4
us-gaap:goodwill,18304000000,FI2018Q1
us-gaap:impairmentofintangibleassetsexcludinggoodwill,80000000,FD2017Q1QTD
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,2003000000,FD2017Q1QTD
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,142000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,5610000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,417000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,5160000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,33000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,6280000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,413000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,5804000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,63000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,1345000000,FD2018Q1YTD
us-gaap:incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest,1332000000,FD2018Q1YTD_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:incometaxexpensebenefit,447000000,FD2017Q1QTD
us-gaap:incometaxexpensebenefit,604000000,FD2018Q1YTD
us-gaap:incometaxexpensebenefit,602000000,FD2018Q1YTD_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:increasedecreaseinoperatingcapital,2535000000,FD2017Q1QTD
us-gaap:increasedecreaseinoperatingcapital,1473000000,FD2018Q1YTD
us-gaap:intangibleassetsnetexcludinggoodwill,14183000000,FI2017Q4
us-gaap:intangibleassetsnetexcludinggoodwill,13500000000,FI2018Q1
us-gaap:interestexpense,182000000,FD2017Q1QTD
us-gaap:interestexpense,182000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:interestexpense,185000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:interestexpense,185000000,FD2018Q1YTD
us-gaap:interestpaid,162000000,FD2017Q1QTD
us-gaap:interestpaid,186000000,FD2018Q1YTD
us-gaap:inventoryfinishedgoods,1334000000,FI2017Q4
us-gaap:inventoryfinishedgoods,1530000000,FI2018Q1
us-gaap:inventorygross,6238000000,FI2017Q4
us-gaap:inventorygross,6493000000,FI2018Q1
us-gaap:inventorynet,5096000000,FI2017Q4
us-gaap:inventorynet,5382000000,FI2018Q1
us-gaap:inventorynet,13000000,FI2018Q1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member
us-gaap:inventorynet,5395000000,FI2018Q1_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:inventorynoncurrent,1187000000,FI2017Q4
us-gaap:inventorynoncurrent,80000000,FI2017Q4_us-gaap_PublicUtilitiesInventoryAxis_mrk_InventoriesProducedinPreparationforProductLaunchesMember
us-gaap:inventorynoncurrent,1100000000,FI2017Q4_us-gaap_PublicUtilitiesInventoryAxis_mrk_InventoryNotExpectedtobeSoldWithinOneYearMember
us-gaap:inventorynoncurrent,1136000000,FI2018Q1
us-gaap:inventorynoncurrent,18000000,FI2018Q1_us-gaap_PublicUtilitiesInventoryAxis_mrk_InventoriesProducedinPreparationforProductLaunchesMember
us-gaap:inventorynoncurrent,1100000000,FI2018Q1_us-gaap_PublicUtilitiesInventoryAxis_mrk_InventoryNotExpectedtobeSoldWithinOneYearMember
us-gaap:inventoryworkinprocessandrawmaterials,4703000000,FI2017Q4
us-gaap:inventoryworkinprocessandrawmaterials,4764000000,FI2018Q1
us-gaap:investmentincomeinterest,97000000,FD2017Q1QTD
us-gaap:investmentincomeinterest,97000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:investmentincomeinterest,85000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:investmentincomeinterest,85000000,FD2018Q1YTD
us-gaap:liabilitiesandstockholdersequity,87872000000,FI2017Q4
us-gaap:liabilitiesandstockholdersequity,86041000000,FI2018Q1
us-gaap:liabilitiescurrent,18614000000,FI2017Q4
us-gaap:liabilitiescurrent,16960000000,FI2018Q1
us-gaap:liabilitiesfairvaluedisclosurerecurring,217000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:liabilitiesfairvaluedisclosurerecurring,935000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:liabilitiesfairvaluedisclosurerecurring,1152000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:liabilitiesfairvaluedisclosurerecurring,324000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:liabilitiesfairvaluedisclosurerecurring,919000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:liabilitiesfairvaluedisclosurerecurring,1243000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:litigationreserve,160000000,FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_mrk_LegalDefenseCostsMember
us-gaap:litigationreserve,155000000,FI2018Q1_us-gaap_ValuationAllowancesAndReservesTypeAxis_mrk_LegalDefenseCostsMember
us-gaap:litigationsettlementamountawardedfromotherparty,200000000,D2016Q1Mar2016_us-gaap_LitigationCaseAxis_mrk_GileadPatentCaseMember
us-gaap:litigationsettlementamountawardedfromotherparty,2540000000,D2016Q4Dec_us-gaap_LitigationCaseAxis_mrk_GileadPatentCaseMember
us-gaap:litigationsettlementamountawardedtootherparty,4300000,D2018Q2April9_us-gaap_ProductOrServiceAxis_mrk_PropeciaProscarMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember
us-gaap:litigationsettlementamountawardedtootherparty,27300000,FD2014Q4YTD_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_OnjLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:longtermdebtnoncurrent,21353000000,FI2017Q4
us-gaap:longtermdebtnoncurrent,21501000000,FI2018Q1
us-gaap:losscontingencyclaimsdismissednumber,650,D2014Q1Mar_us-gaap_LitigationCaseAxis_mrk_FederalMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_FemurFractureLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencyclaimsdismissednumber,1100,D2015Q3Nov_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember
us-gaap:losscontingencyclaimsdismissednumber,510,FD2018Q1YTD_us-gaap_LitigationCaseAxis_mrk_FederalMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_FemurFractureLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencynumberofplaintiffs,15,FD2018Q1YTD_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_CasesallegingcancerMember_us-gaap_ProductOrServiceAxis_mrk_PropeciaProscarMember
us-gaap:losscontingencypendingclaimsnumber,280,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_CaliforniaStateCourtMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_FemurFractureLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencypendingclaimsnumber,540,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_FederalMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_FemurFractureLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencypendingclaimsnumber,2700,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_NewJerseyMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_FemurFractureLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencypendingclaimsnumber,4,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_OtherStateCourtMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_FemurFractureLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencypendingclaimsnumber,7,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_OtherStateCourtMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember
us-gaap:losscontingencypendingclaimsnumber,4,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_OtherStateCourtMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember_us-gaap_StatementGeographicalAxis_stpr_IL
us-gaap:losscontingencypendingclaimsnumber,1,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_OtherStateCourtMember_us-gaap_ProductOrServiceAxis_mrk_PropeciaProscarMember_us-gaap_StatementGeographicalAxis_stpr_CA
us-gaap:losscontingencypendingclaimsnumber,1,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_OtherStateCourtMember_us-gaap_ProductOrServiceAxis_mrk_PropeciaProscarMember_us-gaap_StatementGeographicalAxis_stpr_MA
us-gaap:losscontingencypendingclaimsnumber,1,FI2018Q1_us-gaap_LitigationCaseAxis_mrk_OtherStateCourtMember_us-gaap_ProductOrServiceAxis_mrk_PropeciaProscarMember_us-gaap_StatementGeographicalAxis_stpr_OH
us-gaap:losscontingencypendingclaimsnumber,50,FI2018Q1_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_CasesCompanyAgreedToTollStatuteOfLimitationsMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember
us-gaap:losscontingencypendingclaimsnumber,4030,FI2018Q1_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_FemurFractureLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencypendingclaimsnumber,10,FI2018Q1_us-gaap_LossContingenciesByNatureOfContingencyAxis_mrk_OnjLitigationMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencypendingclaimsnumber,4040,FI2018Q1_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember
us-gaap:losscontingencypendingclaimsnumber,1245,FI2018Q1_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember
us-gaap:losscontingencypendingclaimsnumber,600,FI2018Q1_us-gaap_ProductOrServiceAxis_mrk_PropeciaProscarMember
us-gaap:marketablesecuritiescurrent,2406000000,FI2017Q4
us-gaap:marketablesecuritiescurrent,2863000000,FI2018Q1
us-gaap:marketablesecuritiesnoncurrent,12125000000,FI2017Q4
us-gaap:marketablesecuritiesnoncurrent,11033000000,FI2018Q1
us-gaap:minorityinterest,233000000,FI2017Q4
us-gaap:minorityinterest,233000000,FI2018Q1
us-gaap:minorityinterestchangeinredemptionvalue,1000000,FD2017Q1QTD
us-gaap:minorityinterestchangeinredemptionvalue,1000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:minorityinterestdecreasefromdistributionstononcontrollinginterestholders,5000000,FD2018Q1YTD
us-gaap:minorityinterestdecreasefromdistributionstononcontrollinginterestholders,5000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:netcashprovidedbyusedinfinancingactivities,1461000000,FD2017Q1QTD
us-gaap:netcashprovidedbyusedininvestingactivities,3193000000,FD2017Q1QTD
us-gaap:netcashprovidedbyusedinoperatingactivities,286000000,FD2017Q1QTD
us-gaap:netcashprovidedbyusedinoperatingactivities,1155000000,FD2018Q1YTD
us-gaap:netincomeloss,1551000000,FD2017Q1QTD
us-gaap:netincomeloss,1551000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:netincomeloss,736000000,FD2018Q1YTD
us-gaap:netincomeloss,725000000,FD2018Q1YTD_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:netincomeloss,736000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:netincomelossattributabletononcontrollinginterest,5000000,FD2017Q1QTD
us-gaap:netincomelossattributabletononcontrollinginterest,5000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:netincomelossattributabletononcontrollinginterest,5000000,FD2018Q1YTD
us-gaap:netincomelossattributabletononcontrollinginterest,5000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:newaccountingpronouncementorchangeinaccountingprinciplecumulativeeffectofchangeonequityornet,48000000,I2018Q1Jan1
us-gaap:newaccountingpronouncementorchangeinaccountingprinciplecumulativeeffectofchangeonequityornet,322000000,I2018Q1Jan1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:noncontrollinginterestincreasefrombusinesscombination,25000000,FD2017Q1QTD
us-gaap:noncontrollinginterestincreasefrombusinesscombination,25000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:numberofinterestratederivativesheld,26,FI2018Q1
us-gaap:numberofinterestratederivativesheld,4,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A1.30NotesDue2018Member
us-gaap:numberofinterestratederivativesheld,5,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A1.85NotesDue2020Member
us-gaap:numberofinterestratederivativesheld,5,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A2.35NotesDue2022Member
us-gaap:numberofinterestratederivativesheld,4,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A2.40NotesDue2022Member
us-gaap:numberofinterestratederivativesheld,5,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A3.875NotesDue2021Member
us-gaap:numberofinterestratederivativesheld,3,FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_LongtermDebtTypeAxis_mrk_A5.00NotesDue2019Member
us-gaap:numberofoperatingsegments,4,FD2018Q1YTD
us-gaap:ocibeforereclassificationsbeforetaxattributabletoparent,83000000,FD2017Q1QTD
us-gaap:ocibeforereclassificationsbeforetaxattributabletoparent,87000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:ocibeforereclassificationsbeforetaxattributabletoparent,263000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember
us-gaap:ocibeforereclassificationsbeforetaxattributabletoparent,319000000,FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember
us-gaap:ocibeforereclassificationsbeforetaxattributabletoparent,25000000,FD2018Q1YTD
us-gaap:ocibeforereclassificationsnetoftaxattributabletoparent,223000000,FD2017Q1QTD
us-gaap:ocibeforereclassificationsnetoftaxattributabletoparent,5000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember
us-gaap:ocibeforereclassificationsnetoftaxattributabletoparent,80000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:ocibeforereclassificationsnetoftaxattributabletoparent,309000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember
us-gaap:ocibeforereclassificationsnetoftaxattributabletoparent,2000000,FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember
us-gaap:ocibeforereclassificationsnetoftaxattributabletoparent,257000000,FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember
us-gaap:ocibeforereclassificationsnetoftaxattributabletoparent,4000000,FD2018Q1YTD
us-gaap:otherassetsnoncurrent,171000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:otherassetsnoncurrent,171000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_EquitySecuritiesMember
us-gaap:otherassetsnoncurrent,481000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:otherassetsnoncurrent,66000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,128000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,1000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,79000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,207000000,FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,652000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:otherassetsnoncurrent,66000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,128000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,171000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_EquitySecuritiesMember
us-gaap:otherassetsnoncurrent,1000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,79000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,207000000,FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,232000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:otherassetsnoncurrent,168000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_EquitySecuritiesMember
us-gaap:otherassetsnoncurrent,64000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,410000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:otherassetsnoncurrent,52000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,119000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,78000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,161000000,FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,642000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember
us-gaap:otherassetsnoncurrent,52000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_AssetBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,119000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember
us-gaap:otherassetsnoncurrent,168000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_EquitySecuritiesMember
us-gaap:otherassetsnoncurrent,78000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_MortgageBackedSecuritiesMember
us-gaap:otherassetsnoncurrent,225000000,FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember
us-gaap:othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletopar,43000000,FD2017Q1QTD
us-gaap:othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionatt,309000000,FD2017Q1QTD
us-gaap:othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionatt,257000000,FD2018Q1YTD
us-gaap:othercomprehensiveincomelossbeforereclassificationstax,7000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:othercomprehensiveincomelossbeforereclassificationstax,62000000,FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember
us-gaap:othercomprehensiveincomelossbeforereclassificationstax,21000000,FD2018Q1YTD
us-gaap:othercomprehensiveincomelossnetoftax,146000000,FD2017Q1QTD
us-gaap:othercomprehensiveincomelossnetoftax,146000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember
us-gaap:othercomprehensiveincomelossnetoftax,124000000,FD2018Q1YTD
us-gaap:othercomprehensiveincomelossnetoftax,124000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember
us-gaap:othercomprehensiveincomelossnetoftaxportionattributabletoparent,146000000,FD2017Q1QTD
us-gaap:othercomprehensiveincomelossnetoftaxportionattributabletoparent,26000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember
us-gaap:othercomprehensiveincomelossnetoftaxportionattributabletoparent,43000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:othercomprehensiveincomelossnetoftaxportionattributabletoparent,309000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember
us-gaap:othercomprehensiveincomelossnetoftaxportionattributabletoparent,36000000,FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember
us-gaap:othercomprehensiveincomelossnetoftaxportionattributabletoparent,257000000,FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember
us-gaap:othercomprehensiveincomelossnetoftaxportionattributabletoparent,124000000,FD2018Q1YTD
us-gaap:otherinventorysupplies,201000000,FI2017Q4
us-gaap:otherinventorysupplies,199000000,FI2018Q1
us-gaap:otherliabilitiescurrent,10427000000,FI2017Q4
us-gaap:otherliabilitiescurrent,100000000,FI2017Q4_us-gaap_CounterpartyNameAxis_mrk_AstraZenecaMember_us-gaap_ProductOrServiceAxis_mrk_LynparzaMember
us-gaap:otherliabilitiescurrent,9709000000,FI2018Q1
us-gaap:otherliabilitiescurrent,150000000,FI2018Q1_us-gaap_CounterpartyNameAxis_mrk_AstraZenecaMember_us-gaap_ProductOrServiceAxis_mrk_LynparzaMember
us-gaap:otherliabilitiescurrent,9706000000,FI2018Q1_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:otherliabilitiesnoncurrent,11117000000,FI2017Q4
us-gaap:otherliabilitiesnoncurrent,11473000000,FI2018Q1
us-gaap:othernoncashincomeexpense,28000000,FD2017Q1QTD
us-gaap:othernonoperatingincomeexpense,71000000,FD2017Q1QTD
us-gaap:othernonoperatingincomeexpense,291000000,FD2018Q1YTD
us-gaap:paymentsforproceedsfromotherinvestingactivities,52000000,FD2017Q1QTD
us-gaap:paymentsforproceedsfromotherinvestingactivities,269000000,FD2018Q1YTD
us-gaap:paymentsforrepurchaseofcommonstock,1019000000,FD2017Q1QTD
us-gaap:paymentsforrepurchaseofcommonstock,566000000,FD2018Q1YTD
us-gaap:paymentsforrestructuring,203000000,FD2018Q1YTD
us-gaap:paymentsforrestructuring,139000000,FD2018Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember
us-gaap:paymentsforrestructuring,64000000,FD2018Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:paymentsofdividendscommonstock,1294000000,FD2017Q1QTD
us-gaap:paymentsofdividendscommonstock,1299000000,FD2018Q1YTD
us-gaap:paymentstoacquireadditionalinterestinsubsidiaries,18000000,FD2017Q4QTD_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:paymentstoacquirebusinessesgross,358000000,D2017Q1Mar_us-gaap_BusinessAcquisitionAxis_mrk_ValleeSAMember
us-gaap:paymentstoacquirebusinessesnetofcashacquired,306000000,FD2017Q1QTD
us-gaap:paymentstoacquireintangibleassets,750000000,D2017Q3July_us-gaap_CounterpartyNameAxis_mrk_AstraZenecaMember
us-gaap:paymentstoacquireintangibleassets,325000000,D2019Q1Jan01-Jan31_us-gaap_CounterpartyNameAxis_mrk_EisaiMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember
us-gaap:paymentstoacquireintangibleassets,200000000,D2020Q1Jan01-Jan31_us-gaap_CounterpartyNameAxis_mrk_EisaiMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember
us-gaap:paymentstoacquireintangibleassets,125000000,D2021Q1Jan01-Jan31_us-gaap_CounterpartyNameAxis_mrk_EisaiMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember
us-gaap:paymentstoacquireintangibleassets,650000000,D2021Q1Mar01-Jan31_us-gaap_CounterpartyNameAxis_mrk_EisaiMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember
us-gaap:paymentstoacquireintangibleassets,250000000,FD2017Q4YTD_us-gaap_CounterpartyNameAxis_mrk_AstraZenecaMember
us-gaap:paymentstoacquiremarketablesecurities,2929000000,FD2017Q1QTD
us-gaap:paymentstoacquiremarketablesecurities,1326000000,FD2018Q1YTD
us-gaap:paymentstoacquireproductiveassets,339000000,FD2017Q1QTD
us-gaap:paymentstoacquireproductiveassets,450000000,FD2018Q1YTD
us-gaap:proceedsfromrepaymentsofshorttermdebt,3784000000,FD2017Q1QTD
us-gaap:proceedsfromsalematurityandcollectionsofinvestments,6819000000,FD2017Q1QTD
us-gaap:proceedsfromsalematurityandcollectionsofinvestments,1848000000,FD2018Q1YTD
us-gaap:proceedsfromsaleofintangibleassets,50000000,FD2017Q1QTD
us-gaap:proceedsfromsaleofintangibleassets,21000000,FD2018Q1YTD
us-gaap:proceedsfromstockoptionsexercised,313000000,FD2017Q1QTD
us-gaap:proceedsfromstockoptionsexercised,230000000,FD2018Q1YTD
us-gaap:profitloss,1556000000,FD2017Q1QTD
us-gaap:profitloss,741000000,FD2018Q1YTD
us-gaap:propertyplantandequipmentnet,12439000000,FI2017Q4
us-gaap:propertyplantandequipmentnet,12561000000,FI2018Q1
us-gaap:reclassificationfromaocicurrentperiodbeforetaxattributabletoparent,124000000,FD2017Q1QTD
us-gaap:reclassificationfromaocicurrentperiodbeforetaxattributabletoparent,95000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
us-gaap:reclassificationfromaocicurrentperiodbeforetaxattributabletoparent,57000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:reclassificationfromaocicurrentperiodnetoftaxattributabletoparent,77000000,FD2017Q1QTD
us-gaap:reclassificationfromaocicurrentperiodnetoftaxattributabletoparent,61000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
us-gaap:reclassificationfromaocicurrentperiodnetoftaxattributabletoparent,37000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:reclassificationfromaocicurrentperiodtax,47000000,FD2017Q1QTD
us-gaap:reclassificationfromaocicurrentperiodtax,34000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
us-gaap:reclassificationfromaocicurrentperiodtax,20000000,FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:reclassificationfromaocicurrentperiodtax,1000000,FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:repaymentsoflongtermdebt,300000000,FD2017Q1QTD
us-gaap:repaymentsoflongtermdebt,1003000000,FD2018Q1YTD
us-gaap:researchanddevelopmentexpense,1830000000,FD2017Q1QTD
us-gaap:researchanddevelopmentexpense,1632000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:researchanddevelopmentexpense,2350000000,FD2017Q4YTD_us-gaap_CounterpartyNameAxis_mrk_AstraZenecaMember
us-gaap:researchanddevelopmentexpense,2982000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:researchanddevelopmentexpense,1400000000,FD2018Q1QTD_us-gaap_CounterpartyNameAxis_mrk_EisaiMember
us-gaap:researchanddevelopmentexpense,3196000000,FD2018Q1YTD
us-gaap:restrictedcashandcashequivalents,4000000,FI2017Q4
us-gaap:restrictedcashandcashequivalents,3000000,FI2018Q1
us-gaap:restructuringandrelatedcostcostincurredtodate1,13600000000,FI2018Q1
us-gaap:restructuringandrelatedcostexpectedcostremaining1,500000000,FI2018Q1
us-gaap:restructuringandrelatedcostincurredcost,215000000,FD2017Q1QTD
us-gaap:restructuringandrelatedcostincurredcost,63000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember
us-gaap:restructuringandrelatedcostincurredcost,51000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RestructuringCostAndReserveAxis_mrk_AcceleratedDepreciationMember
us-gaap:restructuringandrelatedcostincurredcost,12000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,2000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,151000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember
us-gaap:restructuringandrelatedcostincurredcost,84000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember
us-gaap:restructuringandrelatedcostincurredcost,67000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,1000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember
us-gaap:restructuringandrelatedcostincurredcost,1000000,FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,49000000,FD2017Q1QTD_us-gaap_RestructuringCostAndReserveAxis_mrk_AcceleratedDepreciationMember
us-gaap:restructuringandrelatedcostincurredcost,84000000,FD2017Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember
us-gaap:restructuringandrelatedcostincurredcost,82000000,FD2017Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,6000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember
us-gaap:restructuringandrelatedcostincurredcost,6000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,2000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember
us-gaap:restructuringandrelatedcostincurredcost,5000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,95000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember
us-gaap:restructuringandrelatedcostincurredcost,55000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember
us-gaap:restructuringandrelatedcostincurredcost,40000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostincurredcost,1000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember
us-gaap:restructuringandrelatedcostincurredcost,1000000,FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RestructuringCostAndReserveAxis_mrk_AcceleratedDepreciationMember
us-gaap:restructuringandrelatedcostincurredcost,104000000,FD2018Q1YTD
us-gaap:restructuringandrelatedcostincurredcost,55000000,FD2018Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember
us-gaap:restructuringandrelatedcostincurredcost,51000000,FD2018Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringandrelatedcostnumberofpositionseliminated,545,FD2017Q1QTD
us-gaap:restructuringandrelatedcostnumberofpositionseliminated,710,FD2018Q1YTD
us-gaap:restructuringandrelatedcostnumberofpositionseliminatedinceptiontodate,44060,FI2018Q1
us-gaap:restructuringcharges,151000000,FD2017Q1QTD
us-gaap:restructuringcharges,151000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:restructuringcharges,95000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember
us-gaap:restructuringcharges,95000000,FD2018Q1YTD
us-gaap:restructuringreserve,747000000,FI2017Q4
us-gaap:restructuringreserve,619000000,FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember
us-gaap:restructuringreserve,128000000,FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:restructuringreserve,651000000,FI2018Q1
us-gaap:restructuringreserve,535000000,FI2018Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember
us-gaap:restructuringreserve,116000000,FI2018Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember
us-gaap:retainedearningsaccumulateddeficit,41350000000,FI2017Q4
us-gaap:retainedearningsaccumulateddeficit,41107000000,FI2018Q1
us-gaap:retainedearningsaccumulateddeficit,41091000000,FI2018Q1_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:retainedearningsaccumulateddeficit,266000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_mrk_AccountingStandardUpdate201802Member
us-gaap:retainedearningsaccumulateddeficit,5000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member
us-gaap:retainedearningsaccumulateddeficit,8000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201601Member
us-gaap:retainedearningsaccumulateddeficit,54000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201616Member
us-gaap:retainedearningsaccumulateddeficit,322000000,I2018Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_NewAccountingPronouncementMember
us-gaap:salesdiscountsgoods,2500000000,FD2017Q1QTD
us-gaap:salesdiscountsgoods,2400000000,FD2018Q1YTD
us-gaap:salesrevenuegoodsnet,9434000000,FD2017Q1QTD
us-gaap:salesrevenuegoodsnet,216000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember
us-gaap:salesrevenuegoodsnet,57000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,159000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,9218000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember
us-gaap:salesrevenuegoodsnet,84000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AdempasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,84000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AdempasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,103000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ArcoxiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,103000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ArcoxiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,49000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AtozetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,49000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AtozetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,42000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BelsomraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,20000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BelsomraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,21000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BelsomraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,148000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BridionMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,45000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BridionMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,102000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BridionMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,121000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CancidasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,5000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CancidasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,116000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CancidasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,361000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CompanionAnimalsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:salesrevenuegoodsnet,164000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CompanionAnimalsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,197000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CompanionAnimalsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,112000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CozaarHyzaarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,3000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CozaarHyzaarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,109000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CozaarHyzaarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,96000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CubicinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,54000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CubicinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,41000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CubicinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,82000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_DuleraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,75000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_DuleraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,7000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_DuleraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,133000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_EmendMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,86000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_EmendMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,47000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_EmendMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,81000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FollistimAqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,42000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FollistimAqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,40000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FollistimAqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,61000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,1000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,60000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,532000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_GardasilGardasil9Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,398000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_GardasilGardasil9Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,134000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_GardasilGardasil9Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,170000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ImplanonNexplanonMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,132000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ImplanonNexplanonMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,39000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ImplanonNexplanonMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,136000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_InvanzMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,82000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_InvanzMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,54000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_InvanzMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,305000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_IsentressIsentressHDMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,143000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_IsentressIsentressHDMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,162000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_IsentressIsentressHDMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,496000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanumetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,195000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanumetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,302000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanumetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,839000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,507000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,332000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,584000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_KeytrudaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,361000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_KeytrudaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,223000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_KeytrudaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,578000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_LivestockMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:salesrevenuegoodsnet,119000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_LivestockMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,459000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_LivestockMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,139000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NasonexMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,18000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NasonexMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,121000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NasonexMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,141000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NoxafilMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,65000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NoxafilMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,76000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NoxafilMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,160000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NuvaringMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,113000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NuvaringMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,47000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NuvaringMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,995000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_OtherPharmaceuticalMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,309000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_OtherPharmaceuticalMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,688000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_OtherPharmaceuticalMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,163000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_Pneumovax23Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,114000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_Pneumovax23Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,49000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_Pneumovax23Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,62000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_PrimaxinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,62000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_PrimaxinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,355000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ProQuadMMRIIVarivaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,298000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ProQuadMMRIIVarivaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,57000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ProQuadMMRIIVarivaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,229000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RemicadeMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,229000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RemicadeMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,224000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RotateqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,178000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RotateqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,45000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RotateqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,184000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SimponiMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,184000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SimponiMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,186000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SingulairMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,6000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SingulairMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,180000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SingulairMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,66000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_TemodarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,1000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_TemodarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,65000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_TemodarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,241000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_VytorinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,90000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_VytorinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,151000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_VytorinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,378000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZepatierMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,200000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZepatierMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,178000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZepatierMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,334000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZetiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,111000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZetiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,222000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZetiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,154000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZostavaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,109000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZostavaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,45000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZostavaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,939000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:salesrevenuegoodsnet,283000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,656000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,8185000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,3761000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,4424000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,94000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember
us-gaap:salesrevenuegoodsnet,94000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,4138000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,5080000000,FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,94000000,FD2017Q1QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_mrk_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
us-gaap:salesrevenuegoodsnet,705000000,FD2017Q1QTD_us-gaap_StatementGeographicalAxis_country_JP
us-gaap:salesrevenuegoodsnet,4195000000,FD2017Q1QTD_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,5239000000,FD2017Q1QTD_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,419000000,FD2017Q1QTD_us-gaap_StatementGeographicalAxis_mrk_OtherCountriesMember
us-gaap:salesrevenuegoodsnet,1001000000,FD2017Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_AsiaPacificMember
us-gaap:salesrevenuegoodsnet,2629000000,FD2017Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_EMEAMember
us-gaap:salesrevenuegoodsnet,485000000,FD2017Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_LatinAmericaMember
us-gaap:salesrevenuegoodsnet,500000000,FD2017Q4YTD_us-gaap_CounterpartyNameAxis_mrk_BayerAGMember_us-gaap_ProductOrServiceAxis_mrk_AdempasMember
us-gaap:salesrevenuegoodsnet,26000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,10068000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember
us-gaap:salesrevenuegoodsnet,68000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AdempasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,68000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AdempasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,33000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AlliancerevenueLynparzaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,24000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AlliancerevenueLynparzaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,9000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AlliancerevenueLynparzaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,83000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ArcoxiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,83000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ArcoxiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,73000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AtozetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,73000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_AtozetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,54000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BelsomraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,23000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BelsomraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,31000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BelsomraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,204000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BridionMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,80000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BridionMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,124000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_BridionMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,91000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CancidasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,3000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CancidasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,88000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CancidasMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,413000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CompanionAnimalsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:salesrevenuegoodsnet,183000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CompanionAnimalsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,229000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CompanionAnimalsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,120000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CozaarHyzaarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,7000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CozaarHyzaarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,113000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CozaarHyzaarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,98000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CubicinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,47000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CubicinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,51000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_CubicinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,57000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_DuleraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,50000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_DuleraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,7000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_DuleraMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,125000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_EmendMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,79000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_EmendMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,46000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_EmendMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,67000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FollistimAqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,29000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FollistimAqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,39000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FollistimAqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,55000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,57000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_FosamaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,660000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_GardasilGardasil9Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,380000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_GardasilGardasil9Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,280000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_GardasilGardasil9Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,174000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ImplanonNexplanonMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,128000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ImplanonNexplanonMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,46000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ImplanonNexplanonMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,151000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_InvanzMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,91000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_InvanzMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,60000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_InvanzMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,281000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_IsentressIsentressHDMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,128000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_IsentressIsentressHDMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,152000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_IsentressIsentressHDMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,544000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanumetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,192000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanumetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,352000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanumetMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,880000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,465000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,416000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_JanuviaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,1464000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_KeytrudaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,838000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_KeytrudaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,626000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_KeytrudaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,652000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_LivestockMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:salesrevenuegoodsnet,124000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_LivestockMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,529000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_LivestockMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,122000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NasonexMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,1000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NasonexMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,121000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NasonexMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,176000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NoxafilMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,81000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NoxafilMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,94000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NoxafilMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,216000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NuvaringMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,171000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NuvaringMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,46000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_NuvaringMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,989000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_OtherPharmaceuticalMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,273000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_OtherPharmaceuticalMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,717000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_OtherPharmaceuticalMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,179000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_Pneumovax23Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,112000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_Pneumovax23Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,66000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_Pneumovax23Member_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,72000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_PrimaxinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,5000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_PrimaxinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,67000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_PrimaxinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,392000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ProQuadMMRIIVarivaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,312000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ProQuadMMRIIVarivaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,80000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ProQuadMMRIIVarivaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,167000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RemicadeMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,167000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RemicadeMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,193000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RotateqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,151000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RotateqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,42000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_RotateqMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,231000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SimponiMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,231000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SimponiMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,175000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SingulairMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,6000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SingulairMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,170000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_SingulairMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,57000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_TemodarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,1000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_TemodarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,56000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_TemodarMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,167000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_VytorinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,8000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_VytorinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,158000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_VytorinMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,131000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZepatierMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,131000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZepatierMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,305000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZetiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,17000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZetiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,287000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZetiaMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,65000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZostavaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,16000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZostavaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,48000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_ProductOrServiceAxis_mrk_ZostavaxMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,1065000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember
us-gaap:salesrevenuegoodsnet,307000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,758000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_AnimalHealthsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,8919000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember
us-gaap:salesrevenuegoodsnet,3716000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,5202000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_mrk_PharmaceuticalsegmentMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,84000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember
us-gaap:salesrevenuegoodsnet,84000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,4107000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,5960000000,FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,737000000,FD2018Q1QTD_us-gaap_StatementGeographicalAxis_country_JP
us-gaap:salesrevenuegoodsnet,4133000000,FD2018Q1QTD_us-gaap_StatementGeographicalAxis_country_US
us-gaap:salesrevenuegoodsnet,5904000000,FD2018Q1QTD_us-gaap_StatementGeographicalAxis_mrk_InternationalMember
us-gaap:salesrevenuegoodsnet,206000000,FD2018Q1QTD_us-gaap_StatementGeographicalAxis_mrk_OtherCountriesMember
us-gaap:salesrevenuegoodsnet,1238000000,FD2018Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_AsiaPacificMember
us-gaap:salesrevenuegoodsnet,3191000000,FD2018Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_EMEAMember
us-gaap:salesrevenuegoodsnet,532000000,FD2018Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_LatinAmericaMember
us-gaap:salesrevenuegoodsnet,10037000000,FD2018Q1YTD
us-gaap:salesrevenuegoodsnet,10013000000,FD2018Q1YTD_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member
us-gaap:sellinggeneralandadministrativeexpense,2472000000,FD2017Q1QTD
us-gaap:sellinggeneralandadministrativeexpense,2508000000,FD2018Q1YTD
us-gaap:sharebasedcompensation,74000000,FD2017Q1QTD
us-gaap:sharebasedcompensation,80000000,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgr,86000,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgr,121000,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgr,64.20,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgr,55.88,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpecteddividen,0.037,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpecteddividen,0.034,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatil,0.197,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatil,0.195,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinteres,0.020,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinteres,0.027,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod,190000,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod,46000,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverag,7.89,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverag,7.83,FD2018Q1YTD
us-gaap:sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedavera,64.20,FD2017Q1QTD
us-gaap:sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedavera,55.88,FD2018Q1YTD
us-gaap:stockholdersequity,34336000000,FI2017Q4
us-gaap:stockholdersequity,33668000000,FI2018Q1
us-gaap:stockholdersequitybeforetreasurystock,78130000000,FI2017Q4
us-gaap:stockholdersequitybeforetreasurystock,77709000000,FI2018Q1
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,40308000000,FI2016Q4
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,338000000,FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,39939000000,FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,1788000000,FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,220000000,FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,44133000000,FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,40088000000,FI2017Q1
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,106000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,40000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,39899000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,1788000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,251000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,44387000000,FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,34569000000,FI2017Q4
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,39902000000,FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,1788000000,FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,233000000,FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,41350000000,FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,33901000000,FI2018Q1
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,39874000000,FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,1788000000,FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,233000000,FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember
us-gaap:stockholdersequityincludingportionattributabletononcontrollinginterest,41107000000,FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember
us-gaap:stockholdersequityother,40000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember
us-gaap:stockholdersequityother,28000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember
us-gaap:stockholdersequityothershares,7000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:stockholdersequityothershares,5000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:treasurystockshares,880491914,FI2017Q4
us-gaap:treasurystockshares,884622139,FI2018Q1
us-gaap:treasurystocksharesacquired,16000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:treasurystocksharesacquired,10000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:treasurystockvalue,43794000000,FI2017Q4
us-gaap:treasurystockvalue,44041000000,FI2018Q1
us-gaap:treasurystockvalueacquiredcostmethod,1019000000,FD2017Q1QTD
us-gaap:treasurystockvalueacquiredcostmethod,1019000000,FD2017Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:treasurystockvalueacquiredcostmethod,566000000,FD2018Q1YTD
us-gaap:treasurystockvalueacquiredcostmethod,566000000,FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember
us-gaap:weightedaveragenumberdilutedsharesoutstandingadjustment,21000000,FD2017Q1QTD
us-gaap:weightedaveragenumberdilutedsharesoutstandingadjustment,15000000,FD2018Q1YTD
us-gaap:weightedaveragenumberofdilutedsharesoutstanding,2766000000,FD2017Q1QTD
us-gaap:weightedaveragenumberofdilutedsharesoutstanding,2710000000,FD2018Q1YTD
us-gaap:weightedaveragenumberofsharesoutstandingbasic,2745000000,FD2017Q1QTD
us-gaap:weightedaveragenumberofsharesoutstandingbasic,2695000000,FD2018Q1YTD
